385 related articles for article (PubMed ID: 32790644)
1. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
Prudencio M; Humphrey J; Pickles S; Brown AL; Hill SE; Kachergus JM; Shi J; Heckman MG; Spiegel MR; Cook C; Song Y; Yue M; Daughrity LM; Carlomagno Y; Jansen-West K; de Castro CF; DeTure M; Koga S; Wang YC; Sivakumar P; Bodo C; Candalija A; Talbot K; Selvaraj BT; Burr K; Chandran S; Newcombe J; Lashley T; Hubbard I; Catalano D; Kim D; Propp N; Fennessey S; ; Fagegaltier D; Phatnani H; Secrier M; Fisher EM; Oskarsson B; van Blitterswijk M; Rademakers R; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Josephs KA; Thompson EA; Raj T; Ward M; Dickson DW; Gendron TF; Fratta P; Petrucelli L
J Clin Invest; 2020 Nov; 130(11):6080-6092. PubMed ID: 32790644
[TBL] [Abstract][Full Text] [Related]
2. Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration.
Glass JD
J Clin Invest; 2020 Nov; 130(11):5677-5680. PubMed ID: 33074248
[TBL] [Abstract][Full Text] [Related]
3. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.
Pickles S; Gendron TF; Koike Y; Yue M; Song Y; Kachergus JM; Shi J; DeTure M; Thompson EA; Oskarsson B; Graff-Radford NR; Boeve BF; Petersen RC; Wszolek ZK; Josephs KA; Dickson DW; Petrucelli L; Cook CN; Prudencio M
Acta Neuropathol Commun; 2022 Jul; 10(1):107. PubMed ID: 35879741
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
[TBL] [Abstract][Full Text] [Related]
5. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
Agra Almeida Quadros AR; Li Z; Wang X; Ndayambaje IS; Aryal S; Ramesh N; Nolan M; Jayakumar R; Han Y; Stillman H; Aguilar C; Wheeler HJ; Connors T; Lopez-Erauskin J; Baughn MW; Melamed Z; Beccari MS; Olmedo Martínez L; Canori M; Lee CZ; Moran L; Draper I; Kopin AS; Oakley DH; Dickson DW; Cleveland DW; Hyman BT; Das S; Ertekin-Taner N; Lagier-Tourenne C
Acta Neuropathol; 2024 Jan; 147(1):9. PubMed ID: 38175301
[TBL] [Abstract][Full Text] [Related]
6. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
[TBL] [Abstract][Full Text] [Related]
7. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
[TBL] [Abstract][Full Text] [Related]
9. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.
Josephs KA; Whitwell JL; Parisi JE; Petersen RC; Boeve BF; Jack CR; Dickson DW
Eur J Neurol; 2010 Jul; 17(7):969-75. PubMed ID: 20236174
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
[TBL] [Abstract][Full Text] [Related]
12. Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.
Borroni B; Benussi A; Archetti S; Galimberti D; Parnetti L; Nacmias B; Sorbi S; Scarpini E; Padovani A
Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):86-91. PubMed ID: 25352065
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of TDP-43 pathology in FTLD-U subtypes.
Mackenzie IR; Neumann M
Acta Neuropathol; 2017 Jul; 134(1):79-96. PubMed ID: 28466142
[TBL] [Abstract][Full Text] [Related]
14. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration.
Bridel C; van Gils JHM; Miedema SSM; Hoozemans JJM; Pijnenburg YAL; Smit AB; Rozemuller AJM; Abeln S; Teunissen CE
Alzheimers Res Ther; 2023 Mar; 15(1):59. PubMed ID: 36949537
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
16. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
[TBL] [Abstract][Full Text] [Related]
17. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy.
Krus KL; Strickland A; Yamada Y; Devault L; Schmidt RE; Bloom AJ; Milbrandt J; DiAntonio A
Cell Rep; 2022 Jun; 39(13):111001. PubMed ID: 35767949
[TBL] [Abstract][Full Text] [Related]
18. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of
Baughn MW; Melamed Z; López-Erauskin J; Beccari MS; Ling K; Zuberi A; Presa M; Gonzalo-Gil E; Maimon R; Vazquez-Sanchez S; Chaturvedi S; Bravo-Hernández M; Taupin V; Moore S; Artates JW; Acks E; Ndayambaje IS; Agra de Almeida Quadros AR; Jafar-Nejad P; Rigo F; Bennett CF; Lutz C; Lagier-Tourenne C; Cleveland DW
Science; 2023 Mar; 379(6637):1140-1149. PubMed ID: 36927019
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological background of phenotypical variability in frontotemporal dementia.
Josephs KA; Hodges JR; Snowden JS; Mackenzie IR; Neumann M; Mann DM; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):137-53. PubMed ID: 21614463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
